Filament Health Corp N.FH

Primary Symbol: FLHLF

Technology Scientific & Technical Instruments

Filament Health Corp. is a Canada-based clinical-stage natural psychedelic drug development company. The Company’s platform of intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The Company’s first three botanical drug candidates are standardized, purified extracts of Psilocybe cubensis fruiting bodies include: PEX010 Psilocybin - oral delivery (1mg and 25mg), PEX020 Psilocin - oral delivery (dose withheld), and PEX030 Psilocin - sublingual delivery (dose withheld). The Company's preclinical stage drug candidates include AEX010 Ayahuasca - oral delivery (dose withheld), and AEX020 Monoamine Oxidase Inhibitor - oral delivery (dose withheld). The Company’s internal drug discovery and development program is carried out by its wholly owned subsidiary, Psilo Scientific Ltd., and is focused on developing standardized pharmaceutical-grade drug candidates from botanical psychedelic biomass.

GREY:FLHLF - Post by User

Filament Health Corp

<< Previous

Bullboard Posts

Next >>

(56)
•••

Post by dothemathpeopleon Feb 25, 2025 10:27am

74 Views

Post# 36467806

Is this company about to delist?

Seems like nobody is home. Too bad they have paid zero attention, to their market. Maybe when they need more money, they will firm up the stock, and place some higher. But I gotta say it again, I am super unimpressed with this companies IR/PR/MR. It does not exist. And it seems, neither do any revenues.

<< Previous

Bullboard Posts

Next >>

Strategic property acquisition in prolific copper-gold region in BC